Experts can reliably identify interictal epileptiform discharges in routine EEGs in an effort to diagnose and manage patients with either suspected or established epilepsy.
Treatment with brivaracetam may be a potentially effective adjunct therapy in patients with drug-resistant focal or generalized epilepsies with seizures that have not previously responded to or who cannot tolerate levetiracetam.
In the first study of this size, researchers found complex neurocognitive skills, typically acquired later in development, are the most delayed skills in youth with SCN8A‐related epilepsy.
Intermittent and repeated exposure to midazolam administered as a single‐dose nasal spray was generally well tolerated and effective for terminating seizures within 10 minutes in a large proportion of patients who experienced seizure clusters.
There have been 118 more reports of electronic cigarette users suffering seizures since the FDA first warned the public about the danger in April, bringing the total number of reported cases to 127 between 2010 and 2019.
The Food and Drug Administration has granted Orphan Drug designation to STK-001 (Stoke Therapeutics) for the treatment of Dravet syndrome.
Focal epilepsy may accelerate widespread progressive cortical thinning to a greater degree than that observed in normal aging.
Epilepsy and refractory epilepsy is less likely to be associated with stroke in older adult survivors and more likely to be associated with younger age and other factors.
Patients with MS and comorbid seizures or epilepsy presenting to a neurology department in at one hospital in Germany between 2003 and 2015 were identified.
The FDA has accepted for review a New Drug Application for ET-105, a new liquid formulation of lamotrigine.
